Shop Research About Compliance Affiliate Free Consultation

Tesamorelin

GHRH Analog · FDA-Studied for Visceral Adiposity

GHRH analog. Studied in visceral adipose tissue and GH secretion models.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Ships in 24hr ✓ US-Based ✓ Direct Support
📋 Certificate of Analysis Request COA via Telegram
Tesamorelin research peptide vial
Select Size
$275
10-vial kit
+ $40 shipping · Free over $1,000 per tier · US: 2-5 day UPS · Intl: 7-14 day
✓ Added to cart View Cart →
Research Data

What Is Tesamorelin?

Tesamorelin is a synthetic GHRH analog (trans-3-hexenoic acid-modified) with FDA approval for HIV-associated lipodystrophy. Phase 3 data demonstrated significant visceral adipose tissue (VAT) reduction and improved metabolic markers. As a GHRH analog, it stimulates endogenous GH release from the pituitary rather than providing exogenous GH directly.

Research Context

  • Visceral adipose tissue reduction via GHRH-driven GH axis stimulation
  • Lipodystrophy and metabolic syndrome models (FDA approval basis)
  • GH and IGF-1 elevation through endogenous pituitary stimulation
  • Cardiovascular risk factor modulation: triglycerides, HDL, inflammatory markers
  • Comparison with other GHRH analogs (CJC-1295) for clinical translation research

Storage & Reconstitution

Store lyophilized at -20°C. Reconstituted: 2–8°C, use within 4–6 weeks.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.